Toxic debate over lab leak theory hampers search for Covid origins
US agencies cannot agree on how the pandemic started, with the scientific community bitterly divided.
US agencies cannot agree on how the pandemic started, with the scientific community bitterly divided.
Winter can wreak havoc on the skin — but there are smart steps to take to protect and nourish it during the colder months. “Most people know the impact that the summer weather and UV rays can have on the skin, but not everyone is aware that they need to take just as much care…
Reckitt/Mead Johnson Nutrition has voluntarily recalled certain Nutramigen Hypoallergenic Infant Formula Powder products due to possible Cronobacter sakazakii contamination. Courtesy: Reckitt/Mead Johnson Baby formula maker Reckitt Benckiser’s Mead Johnson Nutrition has voluntarily chosen to recall certain batches of baby formula powder due to possible bacterial contamination, according to the U.S. Food and Drug Administration. The…
Image source, Getty Images The latest Covid booster campaign is under way across the UK and those who qualify are urged to get jabbed as soon as possible. No Covid restrictions are in place across the UK, but guidance recommends people who catch the virus “should try to stay at home”. What are the Covid…
If you want to refresh your beard grooming routine at home between barbershop appointments, the first upgrade you need is a quality trimmer to keep your facial hair in shape. Because there are tons out there to choose from, we asked real barbers to share the trimmers they actually use in their shops to get perfect results. One…
Bristol Myers Squibb on Friday announced it agreed to buy biopharmaceutical company Karuna Therapeutics for $14 billion in cash, or $330 per share. Karuna’s stock closed up more than 47% on the news Friday, hitting $317.85 a share. Bristol Myers Squibb shares closed up 2%. The deal will help expand Bristol Myers’ drug pipeline after…
A sign hangs in front of the world headquarters of Vertex Pharmaceuticals in Boston on Oct. 23, 2019. Brian Snyder | Reuters Shares of Vertex Pharmaceuticals jumped Wednesday after the company’s painkiller, which is being tested as an alternative to opioids, significantly decreased pain in a midstage trial. Those positive results for diabetes patients suffering…